TPEX/7729 (TPEX/7729)

Taipei Exchange: TPEX/7729 · TWD

NT$171

-3.00 (-1.7%)· Recorded snapshot

Market cap	14B
Net income (ttm)	-204.5M
EPS (ttm)	-NT$3.03
Shares out	80.6M
Volume	1,025,319
Beta	-0.40

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -204.5M
EPS (ttm): -NT$3.03
Market cap: 14B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-31.7

P25 n/aP50 n/aP75 n/a

ROIC-18.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TPEX/7729 indicators

Market & fundamental data

Available fields

148

Groups with data

Currency

TWD

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	TWD
Country	Taiwan
Country code	TW
Earnings date	2026-12-18
Enterprise value	TWD 9.7B
Exchange	Taipei Exchange
Financial currency	TWD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2009
Industry	Biotechnology
Is primary listing	Yes
ISIN number	TW0007729006
Last refreshed	2026-10-28
Market cap	TWD 14B
Next earnings date	2026-12-18
Price	TWD 170.50
Price currency	TWD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tpex/7729
Website	https://steminent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.77%
FCF / EV yield	-1.84%
FCF yield	-1.28%
Industry forward P/E	173.93x
P/B ratio	13.89x
Price / tangible book value	13.91x
Sector forward P/E	28.23x
Sector P/E	83.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-17.62%
ROA (5Y)	-21.47%
ROCE	-19.68%
ROE	-31.72%
ROE (5Y)	-52.51%
ROIC	-18.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	TWD -5.1M
Depreciation and amortization	TWD 19.5M
EBIT	TWD -208.5M
EBITDA	TWD -189M
EPS	TWD -3.03
FCF per share	TWD -2.22
Financing cash flow	TWD 905.5M
Free cash flow	TWD -178.8M
Free cash flow minus SBC	TWD -193M
Gross profit	TWD -3.5M
Income taxes	TWD -111,000
Investing cash flow	TWD 26.9M
Net borrowing	TWD -14M
Net cash flow	TWD 759.2M
Net income	TWD -204.5M
Operating cash flow minus SBC	TWD -187.9M
Operating income	TWD -208.5M
Stock-based compensation	TWD 14.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	TWD 12.53
Debt / equity	0.07
Interest coverage	-100.16
Long-term assets	TWD 168.4M
Long-term liabilities	TWD 50.2M
Net cash (debt)	TWD 822M
Net cash / market cap	5.86%
Net cash growth	915.16%
Net debt / equity	-0.81
Piotroski F-Score	3
Property, plant and equipment	TWD 134.5M
Shareholders' equity	TWD 1B
Tangible book value	TWD 1B
Tangible book value per share	TWD 12.51
Total assets	TWD 1.1B
Total cash	TWD 891.6M
Total debt	TWD 69.6M
Total liabilities	TWD 92.9M
WACC	2.06%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	TWD 934M
Current liabilities	TWD 42.7M
Current ratio	21.85
Inventory turnover	0.27
Net working capital	TWD 19.1M
Quick ratio	20.89
Working capital	TWD 891.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-20.73%
Shareholder yield	-20.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	TWD 97.66
1D price change	-1.73%
1M price change	-9.9%
1M total return	-9.9%
1W price change	-1.11%
1W total return	-1.11%
1Y price change	304.33%
1Y return CAGR	310.9%
1Y total return	310.5%
20-day SMA	TWD 191.18
200-day SMA	TWD 92.55
3M price change	122.43%
3M total return	122.43%
50-day SMA	TWD 138.55
50-day SMA vs 200-day SMA	50over200
52-week high	TWD 240.00
52-week high date	2026-10-05
52-week low	TWD 37.85
52-week low date	2025-11-06
6M price change	126.69%
6M total return	130.15%
All-time high	TWD 240.00
All-time high date	2026-10-05
All-time low	TWD 15.25
All-time low date	2025-04-09
Average true range (ATR)	TWD 15.17
Average volume	1.1M
Beta (1Y)	0.63
Beta (2Y)	0.34
Beta (5Y)	-0.4
Change from 52-week high	-28.96%
Change from 52-week low	350.46%
Change from all-time high	-26.04%
Change from all-time low	1,063.93%
Change from open	-1.16%
Day's gap	-0.58%
Dollar volume	TWD 174.8M
High price	TWD 180.50
Low price	TWD 169.50
Monthly RSI	79.07
Open price	TWD 172.50
Position in 52-week range	9.09%
Previous close	TWD 173.50
Price vs 150-day SMA	81.76%
Price vs 20-day SMA	-7.15%
Price vs 200-day SMA	91.78%
Price vs 50-day SMA	28.11%
Relative volume	0.96
RSI	53.02
Sharpe ratio	2
Sortino ratio	5.35
Volume	1M
Weekly RSI	68.62
YTD price change	195.34%
YTD total return	199.85%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62.7M
Shares change (QoQ)	19.35%
Shares change (YoY)	20.73%
Shares held by insiders	2.09%
Shares held by institutions	11.01%
Shares outstanding	80.6M

Deeper analysis on TPEX/7729

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TPEX/7729 report

Is a complete TPEX/7729 research report available?

No complete published report is available for tpex/7729 (TPEX/7729) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/7729 (TPEX/7729)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/7729

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/7729 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TPEX/7729

Frequently asked questions